rss
J NeuroIntervent Surg doi:10.1136/neurintsurg-2012-010326
  • Letter to the Editor

Pipeline, aneurysms and the FDA

  1. Thabele M Leslie-Mazwi2,3
  1. 1Department of NeuroInterventional Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA
  2. 2Department of Interventional Neuroradiology, Massachusetts General Hospital, Boston, Massachusetts, USA
  3. 3Department of Endovasular Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA
  1. Correspondence to Dr Joshua A Hirsch, Department of NeuroInterventional Radiology, Massachusetts General Hospital, 55 Fruit Street, Gray 241B, Boston, MA 02114, USA; hirsch{at}snisonline.org
  • Accepted 29 February 2012
  • Published Online First 22 March 2012

Keywords:

We commend Brinjikji et al on their recent article estimating the proportion of intracranial aneurysms likely to be amenable to treatment with the pipeline embolization device (PED).1 Based on aneurysm and parent artery morphology, 47% of their consecutive sample of 200 aneurysms could theoretically be treated by the PED.

We believe the paper might …

Related Articles

 

Access to JNIS


The Journal of NeuroInterventional Surgery forms part of the subscription to JNNP for both institutions and individuals. Individuals may subscribe separately to JNIS in print and/or Online: Subscribe here

SNIS members receive JNIS in print and can access the journal online via the members' area of the SNIS website

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



SNIS logo